Mesoblast (MESO) EBIT (QoQ) (2017 - 2023)
Mesoblast (MESO) EBIT (QoQ) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Mesoblast | 19.81 Bn | 19.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -957.35% |
| Mar 31, 2023 | -30.04% |
| Dec 31, 2022 | -8.55% |
| Sep 30, 2022 | 115.34% |
| Jun 30, 2022 | -921.51% |
| Mar 31, 2022 | -22.37% |
| Dec 31, 2021 | 18.29% |
| Sep 30, 2021 | 354.73% |
| Jun 30, 2021 | 75.57% |
| Mar 31, 2021 | -10.52% |
| Dec 31, 2020 | 4.18% |
| Sep 30, 2020 | -60.16% |
| Jun 30, 2020 | 14.73% |
| Mar 31, 2020 | 29.81% |
| Dec 31, 2019 | -865.69% |
| Sep 30, 2019 | 114.05% |
| Jun 30, 2019 | 8.74% |
| Mar 31, 2019 | 0.04% |
| Dec 31, 2018 | -270.63% |
| Sep 30, 2018 | 175.47% |